|
Q4 FY2021
As of Jan 30, 2021
|
Q3 FY2021
As of Oct 31, 2020
|
Q2 FY2021
As of Aug 1, 2020
|
Q1 FY2021
As of May 2, 2020
|
Q4 FY2020
As of Feb 1, 2020
|
Q3 FY2020
As of Nov 2, 2019
|
Q2 FY2020
As of Aug 3, 2019
|
Q1 FY2020
As of May 4, 2019
|
Q4 FY2019
As of Feb 2, 2019
|
Q3 FY2019
As of Nov 3, 2018
|
Q2 FY2019
As of Aug 4, 2018
|
Q1 FY2019
As of May 5, 2018
|
Q4 FY2018
As of Feb 3, 2018
|
Q3 FY2018
As of Oct 28, 2017
|
Q2 FY2018
As of Jul 29, 2017
|
Q1 FY2018
As of Apr 29, 2017
|
Q4 FY2017
As of Jan 28, 2017
|
Q3 FY2017
As of Oct 29, 2016
|
Q2 FY2017
As of Jul 30, 2016
|
Q1 FY2017
As of Apr 30, 2016
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Acquired intangible assets, net | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Accrued employee compensation | ||||||||||||||||||||
| Deferred income | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Non-current income taxes payable | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.002 par value; 8,000 shares authorized; no shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.002 par value; 992,000 shares authorized; 675,402 and 663,481 shares issued and outstanding in fiscal 2021 and 2020, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
